Mirum Pharmaceuticals, Inc. MIRM Current ratio

Current ratio at other companies

Gilead SciencesGILD

1.3×0.0×

Rhythm Pharmaceuticals, Inc.RYTM

4.2×+0.9×

LQD

Liquidia CorporationLQDA

2.2×-0.7×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.3×

BridgeBio PharmaBBIO

1.5×-3.0×

Arrowhead ResearchARWR

6.2×+1.1×

FAQ

What is Mirum Pharmaceuticals, Inc.'s current ratio?

Mirum Pharmaceuticals, Inc. (MIRM) reported current ratio of 2.9× in Q2 2026.

How has Mirum Pharmaceuticals, Inc.'s current ratio changed year-over-year?

Mirum Pharmaceuticals, Inc.'s current ratio decreased by 8.8% year-over-year, from 3.1× to 2.9×.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s current ratio?

Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s current ratio has grown at a -26.9% compound annual growth rate (CAGR), from 12.8× to 2.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.